130 related articles for article (PubMed ID: 23294798)
41. Pharmaceuticals and Medical Devices: FDA Oversight.
White RS;
Issue Brief Health Policy Track Serv; 2017 Dec; 2017():1-43. PubMed ID: 29361661
[No Abstract] [Full Text] [Related]
42. Direct-to-consumer advertising of prescription drugs.
Frosch DL; Grande D
LDI Issue Brief; 2010; 15(3):1-4. PubMed ID: 20469541
[TBL] [Abstract][Full Text] [Related]
43. What kind of patients and physicians value direct-to-consumer advertising of prescription drugs.
Gönül FF; Carter F; Wind J
Health Care Manag Sci; 2000 Jun; 3(3):215-26. PubMed ID: 10907324
[TBL] [Abstract][Full Text] [Related]
44. Availability of prescription drugs for bipolar disorder at online pharmacies.
Monteith S; Glenn T; Bauer R; Conell J; Bauer M
J Affect Disord; 2016 Mar; 193():59-65. PubMed ID: 26766033
[TBL] [Abstract][Full Text] [Related]
45. FDA direct-to-consumer advertising for prescription drugs: what are consumer preferences and response tendencies?
Khanfar N; Loudon D; Sircar-Ramsewak F
Health Mark Q; 2007; 24(1-2):77-91. PubMed ID: 19042521
[TBL] [Abstract][Full Text] [Related]
46. Can direct-to-consumer advertising of prescription drugs be effectively regulated?
Lexchin J; Menkes DB
N Z Med J; 2019 Jun; 132(1496):59-65. PubMed ID: 31170134
[TBL] [Abstract][Full Text] [Related]
47. Direct-to-Consumer Prescription Drug Advertising and Patient-Provider Interactions.
Sullivan HW; Aikin KJ; Berktold J; Stein KL; Hoverman VJ
J Am Board Fam Med; 2020; 33(2):279-283. PubMed ID: 32179611
[TBL] [Abstract][Full Text] [Related]
48. Availability and quality of illegitimate somatropin products obtained from the Internet.
Vida RG; Fittler A; Mikulka I; Ábrahám E; Sándor V; Kilár F; Botz L
Int J Clin Pharm; 2017 Feb; 39(1):78-87. PubMed ID: 27888454
[TBL] [Abstract][Full Text] [Related]
49. The educational potential of direct-to-consumer prescription drug advertising.
Kaphingst KA; DeJong W
Health Aff (Millwood); 2004; 23(4):143-50. PubMed ID: 15318574
[TBL] [Abstract][Full Text] [Related]
50. Reforming direct-to-consumer advertising.
Liang BA; Mackey T
Nat Biotechnol; 2011 May; 29(5):397-400. PubMed ID: 21552236
[No Abstract] [Full Text] [Related]
51. Direct-to-consumer advertising: its effects on stakeholders.
Montoya ID; Lee-Dukes G; Shah D
J Allied Health; 2008; 37(2):116-20. PubMed ID: 18630788
[TBL] [Abstract][Full Text] [Related]
52. An Updated Analysis of Direct-to-Consumer Television Advertisements for Prescription Drugs.
Applequist J; Ball JG
Ann Fam Med; 2018 May; 16(3):211-216. PubMed ID: 29760024
[TBL] [Abstract][Full Text] [Related]
53. Association of Attorney Advertising and FDA Action with Prescription Claims: A Time Series Segmented Regression Analysis.
Tippett EC; Chen BK
Drug Saf; 2015 Dec; 38(12):1169-78. PubMed ID: 26384489
[TBL] [Abstract][Full Text] [Related]
54. Selling Health to the Distracted: Consumer Responses to Source Credibility and Ad Appeal Type in a Direct-to-Consumer Advertisement.
Lemanski JL; Villegas J
Health Mark Q; 2015; 32(3):217-33. PubMed ID: 26368298
[TBL] [Abstract][Full Text] [Related]
55. Consumer friendly or reader hostile? An evaluation of the readability of DTC print ads.
Sheehan K
Health Mark Q; 2008; 23(4):1-16. PubMed ID: 19042509
[TBL] [Abstract][Full Text] [Related]
56. Disclosing accelerated approval on direct-to-consumer prescription drug websites.
Sullivan HW; O'Donoghue AC; David KT; Patel NJ
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1277-1280. PubMed ID: 30264874
[TBL] [Abstract][Full Text] [Related]
57. Turning point or tipping point: new FDA draft guidances and the future of DTC advertising.
Pitts PJ
Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-259-61. PubMed ID: 15452001
[TBL] [Abstract][Full Text] [Related]
58. Direct-to-consumer drug marketing: public service or disservice?
Berger JT; Kark P; Rosner F; Packer S; Bennett AJ
Mt Sinai J Med; 2001 May; 68(3):197-202. PubMed ID: 11373692
[TBL] [Abstract][Full Text] [Related]
59. Health literacy knowledge among direct-to-consumer pharmaceutical advertising professionals.
Mackert M
Health Commun; 2011 Sep; 26(6):525-33. PubMed ID: 21469006
[TBL] [Abstract][Full Text] [Related]
60. Disease-specific direct-to-consumer advertising for reminding consumers to take medications.
Bhutada NS; Rollins BL
J Am Pharm Assoc (2003); 2015; 55(4):434-7. PubMed ID: 26161486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
